Papillary Renal Cell Carcinoma Type
📧 Sign up to get email alerts when something new happens for Papillary Renal Cell Carcinoma Type.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) [Phase 2]
Phase 2 study UNICAB evaluating cabozantinib in various non-clear cell renal cell carcinoma subtypes after immunotherapy has been completed.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) [Phase 2]
Phase II trial investigating sequential single-agent nivolumab followed by combination ipilimumab plus nivolumab in metastatic or unresectab…